Navigation Links
Elusys Therapeutics and Lonza Enter Into Manufacturing Agreement
Date:6/16/2009

PINE BROOK, N.J. and BASEL, Switzerland, June 16 /PRNewswire/ -- Elusys Therapeutics and Lonza Sales AG entered into an agreement for the production of Anthim(TM), a therapeutic monoclonal antibody in late stage development for the treatment of anthrax infection. Under this agreement, Lonza will provide process development services and manufacturing capacity for this product using Lonza's GS Gene Expression System(TM).

(Logo: http://www.newscom.com/cgi-bin/prnh/20090420/NY01624LOGO )

(Logo: http://www.newscom.com/cgi-bin/prnh/20090616/NY32818LOGO )

"Elusys is pleased to initiate a partnership with Lonza for the production of Anthim. Lonza has considerable experience in large-scale manufacturing of monoclonal antibodies and a well-established reputation with regulatory agencies for the production of licensed products," commented James Porter, Vice President of Development and Manufacturing at Elusys.

"Elusys has developed a very promising antibody therapeutic and we are proud to be able to support the further development of Anthim towards its commercial use," added Dr. Stephan Kutzer, Head of Lonza Biopharmaceuticals.

Anthim Background

Anthim is a high-affinity, humanized and deimmunized monoclonal antibody that targets the protective antigen of B. anthracis and neutralizes the lethal effects of anthrax toxins. It is being developed for prevention and treatment of inhalation anthrax. Anthim has been granted Fast-Track status and Orphan Drug Designation by the FDA. Elusys has been awarded $34 million from the National Institutes of Health and the Department of Defense for development of Anthim, of which $12 million was awarded in September 2007, under contract
'/>"/>

SOURCE Elusys Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Prime Therapeutics Receives TIPPS Certification
2. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
3. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
4. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
5. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
6. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
7. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
8. Prime Therapeutics Announces URAC Accreditation
9. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
10. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
11. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... (PRWEB) May 19, 2013 HealthEconomics.Com ... access, is pleased to unveil a new and exciting ... that provides a powerful array of real-time communication tools ... the US and abroad. , HE-Xpo is powered by ... attendees the look and feel of being at a ...
(Date:5/19/2013)... The legal team at Pulaski & Middleman, ... effort to connect women and families coping with the ... Yasmin & Ocella with the legal representation they need. ... notorious birth control drugs as well as news and ... Yasmin & Ocella were very popular birth control medications ...
(Date:5/18/2013)... Illinois (PRWEB) May 18, 2013 Cambridge ... in the St. Louis Metro East area, is hosting a ... on Friday, May 24. , The community, which is located ... adults of all incomes, including those on Medicaid, who need ... a delicious BBQ luncheon topped off by homemade ice cream ...
(Date:5/18/2013)... Daily Gossip issued a press release last week to announce ... Colston, Daily Gossip’s spokesperson, told the press that the magazine ... Fat Loss Plan . , Shaun Hadsall was the ... time when nutritionists and fat loss gurus constantly told people ... diet is based on the Macro-Patterning scheme, according ...
(Date:5/18/2013)... 19, 2013) Each year, the American Gastroenterological ... contributions and achievements in gastroenterology through its esteemed ... distinguished and talented individuals who work tirelessly to ... we are pleased to announce the 2013 recognition ... colleagues for their tremendous contributions to our field," ...
Breaking Medicine News(10 mins):Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 3Health News:Yazsideeffects.com Connects Yaz Side Effects Sufferers With Yaz Side Effects Lawyers 2Health News:Metro East Affordable Assisted Living Community to Host Memorial Day Weekend Barbecue 2Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 2Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 3Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 4Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 5
... remake male-oriented Japanese animation videos into romances -- and ... editing, storytelling and feminist literary criticism. "Boys are ... Birmingham, an associate professor of English at North Dakota ... cut the animation videos up, mix them around, and ...
... The Wound Care Education Institute (WCEI) announces the introduction ... certification for sales professionals that are employed in the ... help raise the professional level of knowledge in the ... BSN, MBA, CWCN, WCC, co-founder of WCEI. "Earning ...
... June 18 , , What: At the Drug Information Association,s ... San Diego, Microsoft Corp. will showcase Microsoft, ... such as these:, ... Office System, ...
... ... ... A new survey completed by the British Association of Aesthetic Plastic Surgery (BAAPS) suggests ... types of cosmetic injections. The survey reveals 38.5% of surgeons saw 1-3 patients ...
... Fla., June 18 Connectyx (Pink Sheets: CTYX) - Connectyx ... Company has entered into an agreement with Sabrielle GPS High ... the South East Asia market. The initial sales will ... The agreement allows for the expansion into neighboring countries ...
... , AlphaRx,s inhaled Tobramycin nanoparticle formulation ... free drug in lung tissue, as demonstrated in a, ... , MARKHAM, ON, June 18 /PRNewswire-FirstCall/ - AlphaRx (OTC ... the development of Zysolin(TM), an inhaled Tobramycin nanoparticle formulation ...
Cached Medicine News:Health News:Anime's fan girls 2Health News:Microsoft to Showcase Clinical Trial Solutions From Discovery to Approvals at Drug Information Association's 2009 Annual Meeting 2Health News:Recent Survey Suggests Complications with Permanent Fillers 2Health News:Recent Survey Suggests Complications with Permanent Fillers 3Health News:Recent Survey Suggests Complications with Permanent Fillers 4Health News:Connectyx Technologies Signs Distributor to Serve the Vast South East Asia Market with its MedFlash Electronic Personal Health Record 2Health News:Zysolin(TM) Pre-clinical Data Supports Once-a-day Dosing in Humans 2
(Date:5/17/2013)... , May 17, 2013  Technology advances ... communicate internally. Faced with a constantly evolving communication ... and tactics for communicating with internal executives. It ... all the strategies, tactics and tools that are ... In a new study, Best Practices, LLC explores ...
(Date:5/17/2013)... Research explores data on ... also   to   be presented ... the global specialty biopharmaceutical company, announces that it will ... American Psychiatric Association (APA) 166th Annual Meeting in ... being presented represent Shire,s ongoing commitment to the clinical ...
(Date:5/17/2013)... 2013 Fuse Science, Inc. (OTCQB: DROP), ( www.fusescience.com ... developing new, patent-pending technologies poised to redefine how consumers receive ... hold a business update teleconference and webcast for shareholders and ... at 4:30 PM ET. Fuse Science, Inc. ... call and will be joined by Rubin Hanan ...
Breaking Medicine Technology:Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2
... International Corporation (NASDAQ: PRXL ) will release financial ... Tuesday, August 9, 2011 after the close of the stock ... www.PAREXEL.com and on the PR Newswire website at ... call and live webcast at 10:00 a.m. ET on Wednesday, ...
... PORTLAND, Ore., July 14, 2011 QuantRx® Biomedical ... and commercialization of innovative diagnostic products based on ... industry, today announced that it has settled the ... with prejudice, and will be focusing its operations ...
Cached Medicine Technology:PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2011 Earnings Release and Conference Call 2QuantRx Biomedical Settles Suit: Launches New PAD-Based Genomic Diagnostic Products 2QuantRx Biomedical Settles Suit: Launches New PAD-Based Genomic Diagnostic Products 3
... Kubtec introduces a breakthrough in specimen radiography. The ... up to 65,536 shades of gray in every ... the smallest changes in density that heretofore were ... digital detectors from 2 x 2 to 8 ...
Commode chair....
For complete unobstructed imaging coverage for a wide range of urological procedures, HealthTronics urodynamics Chair/Table is the answer....
... Multi-Sample Osmometer is designed to automate ... high volumes of samples. By using ... for an accurate determination of total ... the Advanced Instruments Model 3900 will ...
Medicine Products: